Form D · Other
Empire Genomics Corp.
Bethesda, MD · CIK 0001854238
Offering snapshot reported Apr 26, 2021 · SEC filing
- Reported sold
- $500K Indefinite offering
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 26, 2021 | Initial | $500,000 | No comparison | Not reported | SEC filing |
| Apr 26, 2021 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Apr 26, 2021 | Initial | Yet to sell | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-397200
Source: Form D, filed Apr 26, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Aaron Fisher | Executive |
| William Snider | Director, Executive, Promoter |
Issuer details
Industry: Other (See others in industry)
Address:
4800 Montgomery Lane Suite 230
Bethesda, MD, 20814
Bethesda, MD, 20814